These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29162215)

  • 21. Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants.
    Kohl C; Steinkellner M
    Drug Metab Dispos; 2000 Feb; 28(2):161-8. PubMed ID: 10640513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic contribution of CYP2C9, CYP2C19, and APOE variants in acenocoumarol response.
    Nastasi-Catanese JA; Padilla-Gutiérrez JR; Valle Y; Ortega-Gutiérrez F; Gallegos-Arreola MP; Figuera LE
    Genet Mol Res; 2013 Oct; 12(4):4413-21. PubMed ID: 24222221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe interaction between ritonavir and acenocoumarol.
    Llibre JM; Romeu J; López E; Sirera G
    Ann Pharmacother; 2002 Apr; 36(4):621-3. PubMed ID: 11918509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged effects of miconazole oral gel on warfarin anticoagulation even after treatment withdrawal.
    Murakami S; Tanaka A; Ido K; Tanaka M; Araki H
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):474-6. PubMed ID: 27117040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people.
    Esmerian MO; Mitri Z; Habbal MZ; Geryess E; Zaatari G; Alam S; Skouri HN; Mahfouz RA; Taher A; Zgheib NK
    J Clin Pharmacol; 2011 Oct; 51(10):1418-28. PubMed ID: 21148049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin.
    Kovac M; Mitic G; Kovac Z
    J Clin Pharm Ther; 2012 Feb; 37(1):45-8. PubMed ID: 21332566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.
    Miki A; Ohtani H; Sawada Y
    J Clin Pharm Ther; 2011 Dec; 36(6):642-50. PubMed ID: 21143257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.
    Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of acenocoumarol and levofloxacin interaction in elderly institutionalized patients.
    Taberner-Bonastre P; Moreno-Miralles A; Quintana-Vargas I; Peris-Martí JF
    Farm Hosp; 2019 Mar; 43(2):53-55. PubMed ID: 30848177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Miconazole buccal gel and risk for systemic bleeding: how certain topical formula can interfere with anticoagulants.
    De Pauw A; De Backer T
    Acta Clin Belg; 2015 Apr; 70(2):121-3. PubMed ID: 25331621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin use decreases coagulation in users of vitamin K antagonists.
    van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acenocoumarol stabilization is delayed in CYP2C93 carriers.
    Schalekamp T; van Geest-Daalderop JH; de Vries-Goldschmeding H; Conemans J; Bernsen Mj Mj; de Boer A
    Clin Pharmacol Ther; 2004 May; 75(5):394-402. PubMed ID: 15116052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ifosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin induced anticoagulant response.
    Okada N; Watanabe H; Kagami S; Ishizawa K
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):58-61. PubMed ID: 26587904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
    Schwarz UI; Stein CM
    Clin Pharmacol Ther; 2006 Jul; 80(1):7-12. PubMed ID: 16815312
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals].
    Benavides F; Grossman N; Poggi H; Nieto E; Bertrán A; Araos D; Vásquez M; Ibarra I; Cáceres F; Espinoza K; Lagos M; Repetto M G
    Rev Med Chil; 2015 Nov; 143(11):1369-76. PubMed ID: 26757860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of the acenocoumarol anticoagulant effect by acetaminophen.
    Bagheri H; Bernhard NB; Montastruc JL
    Ann Pharmacother; 1999 Apr; 33(4):506. PubMed ID: 10332548
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperprothrombinemia as a result of a possible warfarin and intravaginal miconazole interaction.
    Thomas JL; Dunn D; Pelletier A; Franks AS
    South Med J; 2010 Oct; 103(10):1063-5. PubMed ID: 20802381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.